NDC 67457-847 – Ogivri
· Kit
Product NDC67457-847
Product details
- Brand name
- Ogivri
- Generic name
- Trastuzumab
- Labeler
- Mylan Institutional LLC
- Dosage form
- Kit
- Marketing category
- BLA · BLA761074
- Marketed since
- November 29, 2019
- Marketing end
- April 30, 2027
Active ingredients
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 67457-847-44 | 1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20) | Nov 29, 2019 |
Other Ogivri products
- 83257-004 · Kit · Biocon Biologics Inc.
- 83257-001 Trastuzumab 150 mg/7.4mL · Injection, Powder, Lyophilized, For Solution · Biocon Biologics Inc.
- 83257-003 Trastuzumab 420 mg/20mL · Injection, Powder, Lyophilized, For Solution · Biocon Biologics Inc.
- 67457-991 Trastuzumab 150 mg/7.4mL · Injection, Powder, Lyophilized, For Solution · Mylan Institutional LLC